
Change. Empower. Connect.
UNITE
TO RAISE AWARENESS OF GVHD
For those of us living with GVHD, CONNECTING CAN BRING SUPPORT, ENCOURAGEMENT, AND COMFORT and remindus—there is always hope.
—Meredith, survivor
OUR MISSION
The GVHD Alliance is empowering voices in the graft-versus-host disease (GVHD) community to increase awareness and help improve the lives of people living with GVHD.WHO WE ARE
Here you can learn more about the organizations that make up the GVHD Alliance.
HIGHLIGHTS FROM THE GVHD ALLIANCE
Discover where and how we’ve been making an impact and keep up with GVHD news we’re excited about.
Spotlight on the 2025 GVHD National Symposium
October 17, 2025

The 2025 GVHD National Symposium, held in Columbus, OH, brought together physicians, researchers, patients, caregivers, and other stakeholders for a one-day deep dive into the latest science, treatments, and support for GVHD. As the only conference worldwide devoted solely to GVHD, it offered both a scientific track for clinicians and a patient/caregiver track, giving attendees valuable opportunities to learn, connect, and share experiences.
Advancing the Field at The ONE Forum® by NMDP℠
November 6–8, 2025

The ONE Forum® by NMDP℠ took place in Minneapolis, MN, and served as a gathering for professionals across the cell therapy and hematopoietic cell transplant community, including the GVHD Alliance. The event provided a vital space for collaboration on the future of blood and marrow transplantation, featuring discussions on emerging research, policy developments, and operational challenges to help remove barriers to transplant and expand access to life-saving therapies.
The GVHD Alliance Is Expanding to Europe!
Date: June 2025

The GVHD Alliance is excited to announce a partnership with the European Society for Blood and Marrow Transplantation (EBMT) to expand the footprint of education and resources to more patients and families worldwide. EBMT will be working with leading patient advocacy organizations in Europe to determine needed support and programming for people with GVHD. Welcome EBMT!
BMT InfoNet Survivorship 2025
Dates: May 3-9, 2025

More than 2,000 survivors and their loved ones celebrated a second chance at life after bone marrow/stem cell transplant and CAR T-cell therapy. Attendees included members with 45 different diagnoses from 23 countries. Over 90% of participants had experienced GVHD after bone marrow/stem cell transplant.

CHANGEMAKER SPOTLIGHT
Here we recognize the efforts of people who actively improve the lives of people living with GVHD.
See our winners below.

Lukas D. Wartman GVHD Achievement Award Winner
Lukas D. Wartman GVHD Achievement Award Winner
Dr. Shernan Holtan
2025 Winner

About the Lukas D. Wartman GVHD Achievement Award
The Lukas D. Wartman GVHD Achievement Award is given to a health care professional who demonstrates persistent dedication to improving outcomes for patients with GVHD. It is named in honor of Lukas D. Wartman, an oncologist who was diagnosed with leukemia in 2003 and later developed chronic GVHD after 2 bone marrow transplants. Dr. Wartman continues to be a leading advocate for people living with GVHD.
Hear From Dr. Wartman
About the Meredith A. Cowden Patient Advocacy Achievement Award
The Meredith A. Cowden Patient Advocacy Achievement Award was created to recognize advocates who go above and beyond in their efforts to help those in the GVHD community improve their quality of life.
Watch the Video
